Non-alcoholic fatty liver disease: A patient guideline
- Resource Type
- Source
- JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV - Subject
NASH, non-alcoholic steatohepatiti Y GASTRIC BYPASS Disease RC799-869 PLACEBO-CONTROLLED TRIAL LIFE-STYLE MODIFICATION cardiovascular disease LDL, low-density lipoprotein HEPATOCELLULAR-CARCINOMA non-invasive test T2D GLP-1 RAs, glucagon-like receptor 1 agonists European Association for the Study of Obesity HCC Gastroenterology NASH specific Diseases of the digestive system. Gastroenterology CAP controlled attenuation parameter CT, computed tomography FXR ASH, alcoholic steatohepatitis GP non-alcoholic steatohepatitis GLP-1 RAs, glucagon-like receptor 1 agonist LDL, low-density lipoproteins medicine.medical_specialty HDL achievable NASH, non-alcoholic steatohepatitis T2D, type 2 diabetes high-density lipoprotein CVD, cardiovascular disease LDL Patient Guideline Quality of life (healthcare) FXR, farnesoid X receptor NAFLD low-density lipoproteins GP, general practitioner NAFL, non-alcoholic fatty liver FIB-4, fibrosis-4 index Intensive care medicine computed tomography Guideline medicine.disease T1D, type 1 diabete digestive system diseases NIT Human medicine farnesoid X receptor type 1 diabetes BMI, body mass index EASL, European Association for the Study of the Liver Placebo-controlled study Chronic liver disease GLP-1 RAs QUALITY-OF-LIFE alcoholic steatohepatitis European Association for the Study of Diabetes EASD, European Association for the Study of Diabetes Immunology and Allergy magnetic resonance imaging NASH Clinical Research Network ALD, alcohol-related or alcoholic liver disease Disease management (health) glucagon-like receptor 1 agonists EASO, European Association for the Study of Obesity NASH CRN, NASH Clinical Research Network ASH, alcoholic steatohepatiti Fatty liver timely hepatocellular carcinoma CVD magnetic resonance elastography MRE NAFL FIB-4 non-alcoholic fatty liver type 2 diabetes T1D, type 1 diabetes CAP, controlled attenuation parameter CT European Association for the Study of the Liver MRI fibrosis-4 index NAFLD, non-alcoholic fatty liver disease EASD HDL, high-density lipoprotein UNITED-STATES ASH body mass index EASL measurable BMI NIT, non-invasive test Internal Medicine medicine NASH CRN HEPATIC STEATOSIS HCC, hepatocellular carcinoma MRE, magnetic resonance elastography MRI, magnetic resonance imaging SMART, specific, measurable, achievable, relevant, timely Disease burden BARIATRIC SURGERY Hepatology SMART business.industry SERUM ALANINE AMINOTRANSFERASE non-alcoholic fatty liver disease PHYSICAL-ACTIVITY alcohol-related or alcoholic liver disease EASD, European Association for the Study of Diabete EASO ALD general practitioner relevant T1D business - Language
- ISSN
- 2589-5559